Get started
Author

Reshma Ronald Quadros

Observed name: Reshma Quadros
Institution: Sun Pharma (India)
Observed institution: Sun Pharma (India)
ORCID: 0009-0000-1765-3583
Observed ORCID: 0009-0000-1765-3583
OpenAlex ID: A5097767676
Absence of evidence is not evidence of absence for first trimester dydrogesterone-induced birth defects
2024 · Reshma Quadros, Gaurav Puppalwar, et al. · Human Reproduction Open · 5
PDF
Immunomodulatory Role of Natural Progesterone in Pregnancy: A Review
2026 · Prakash Mehta, Hemant Deshpande, et al. · Journal of obstetrics and gynaecology research
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III , Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study
2026 · Sneha Bhoir, Jaldhara Patel, et al. · BJOG An International Journal of Obstetrics & Gynaecology
Module for pharmaceutical industry career orientation for MD Pharmacology students: Recommendations from the National Association of Pharmacology and Therapeutics: Curricular enrichment document
2026 · Jeetendra Singh, Dinesh Kumar Badyal, et al. · National Journal of Pharmacology and Therapeutics
Single‐Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non‐Pregnant, Non‐Lactating Premenopausal Female Subjects Under Fasting Conditions
2026 · Sudershan Kumar, Arshad Khuroo, et al. · Clinical Pharmacology in Drug Development
Expanding horizons of pharmaceutical physicians: Evolving skill sets and career pathways
2024 · C. M. Kamaal, Reshma Ronald Quadros, et al. · National Journal of Pharmacology and Therapeutics
Works count: 6
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type